Clinical trial
Neqpiaput Iinruugut (Our Food is Medicine): Testing a Tribally-driven Intervention to Prevent Heart Disease Among Alaska Native Communities
NCT07897838 is registered in ClinicalTrials.gov with University of Alaska Fairbanks as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neqpiaput Iinruugut (Our Food is Medicine): Testing a Tribally-driven Intervention to Prevent Heart Disease Among Alaska Native Communities
- Lead sponsor
- University of Alaska Fairbanks
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- August 31, 2030
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular (cv) risk
Arms
As registered; 1 arm.
-
Neqpiaput Iinruugut (Our Food Is Our Medicine)
Participants in all three communities will receive the 12-month Neqpiaput Iinruugut intervention. Communities will be randomly assigned to the order in which they begin the intervention, with intervention start dates staggered by 12 months
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in Framingham Risk Score
Estimated 10-year risk of coronary heart disease, using the Framingham Risk Score based on age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, blood pressure medication use, diabetes status, and smoking status. Total and HDL cholesterol are measured from a fasting finger-stick blood sample using a Cholestech LDX point-of-care analyzer, and blood pressure is measured using an OMRON IntelliSense professional digital monitor. Remaining inputs are self-reported on the Demographic and Medical History Questionnaire. Higher scores indicate greater estimated 10-year cardiovascular disease risk.
Papers
PubMed papers this trial cites; 7 papers, results papers first, then newest first.
+2 more papers
Lead sponsor's other trials
University of Alaska Fairbanks, most recent start first.
+1 more trial